Top Markets
Coin of the day
Dali Pharmaceuticalco.,Ltd Dali Pharmaceuticalco.,Ltd

Dali Pharmaceuticalco.,Ltd

603963
Rang in Aktien #27024
Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the... Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the research, development, manufacturing, and distribution of medicinal products. The company specializes in injectable medications, offering a diverse portfolio of both traditional Chinese and Western formulations. This includes 20 distinct drug varieties, with a total of 44 approved specifications. Key examples from their product line are Xingnaojing, Shenmai, Astragalus, Leucocin A, and Citicoline injections. Dali Pharmaceutical also maintains a substantial intellectual property collection, holding 31 patents comprised of 11 invention patents, 16 utility models, and 3 design patents. Established in 1996, the company operates from its headquarters located in Dali, China.
Aktienkurs
$0.16240909
Zuletzt synchronisiert: 2025-03-04
Marktkapitalisierung
$35.68M
Veränderung (1 Tag)
0.27%
Veränderung (1 Jahr)
0.00%
Land
CN
Handel Dali Pharmaceuticalco.,Ltd (603963)

Kategorie

Dividendenhistorie für Dali Pharmaceuticalco.,Ltd (603963)
Dali Pharmaceuticalco.,Ltd (Aktienkürzel: 603963) zahlte insgesamt 3 Dividenden.
Die Summe aller Dividenden (angepasst an Aktiensplits) beträgt: $0.15
Dividendenrendite (TTM): 0
Dividendenzahlungen für Dali Pharmaceuticalco.,Ltd (603963) von 2018 bis 2026
Jährliche Dividendenzahlungen
Jahr Dividende (angepasst an Aktiensplits) ändert
2026 (TTM) $0.046 0.00%
2021 $0.046 -22.30%
2019 $0.0592 30.11%
2018 $0.0455 0.00%
Liste aller Dividendenzahlungen
Jahr Dividende ändert
2026 (TTM) $0.046 0.00%
2021 $0.046 -54.05%
2019 $0.1001 0.10%
2018 $0.1 0.00%
Dividendenzahlungen ähnlicher Unternehmen oder Wettbewerber